BRPI0208558A2 - preparado de combinação de estrogênio-gestagênio e uso - Google Patents

preparado de combinação de estrogênio-gestagênio e uso

Info

Publication number
BRPI0208558A2
BRPI0208558A2 BRPI0208558A BR0208558A BRPI0208558A2 BR PI0208558 A2 BRPI0208558 A2 BR PI0208558A2 BR PI0208558 A BRPI0208558 A BR PI0208558A BR 0208558 A BR0208558 A BR 0208558A BR PI0208558 A2 BRPI0208558 A2 BR PI0208558A2
Authority
BR
Brazil
Prior art keywords
combination
estrogen
gestagen
gestagen combination
Prior art date
Application number
BRPI0208558A
Other languages
English (en)
Inventor
Hachmeister Bernd
Schwanitz Diethard
Rogoll Jutta
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BRPI0208558A2 publication Critical patent/BRPI0208558A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0208558A 2001-09-29 2002-09-25 preparado de combinação de estrogênio-gestagênio e uso BRPI0208558A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01123511 2001-09-29
PCT/EP2002/010728 WO2003028735A1 (de) 2001-09-29 2002-09-25 Estrogen-gestagen kombinationspräparat und anwendung

Publications (1)

Publication Number Publication Date
BRPI0208558A2 true BRPI0208558A2 (pt) 2017-05-23

Family

ID=8178810

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0208558A BRPI0208558A2 (pt) 2001-09-29 2002-09-25 preparado de combinação de estrogênio-gestagênio e uso

Country Status (16)

Country Link
US (1) US20040266745A1 (pt)
EP (1) EP1434586A1 (pt)
JP (1) JP2005507394A (pt)
KR (1) KR20040037097A (pt)
CN (1) CN1561217A (pt)
BR (1) BRPI0208558A2 (pt)
CA (1) CA2462075A1 (pt)
DE (1) DE10294402D2 (pt)
HU (1) HUP0402142A2 (pt)
IL (1) IL161105A0 (pt)
MX (1) MXPA04002771A (pt)
NO (1) NO20034159D0 (pt)
PL (1) PL373494A1 (pt)
RU (1) RU2004113305A (pt)
WO (1) WO2003028735A1 (pt)
ZA (1) ZA200402458B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
EP1761231A1 (en) * 2004-06-07 2007-03-14 Duramed Pharmaceuticals, Inc. Dispenser for progestin used for acute and maintenance treatment of dub
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
JP5675068B2 (ja) * 2009-07-13 2015-02-25 株式会社ミューチュアル 充填装置
PL2547307T3 (pl) 2010-03-18 2015-03-31 Medcomb Holding Aps System do otwierania medycznego opakowania blistrowego
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2024124239A2 (en) * 2022-12-09 2024-06-13 Maple Mountain Group, Inc. Dietary supplement and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method

Also Published As

Publication number Publication date
NO20034159L (no) 2003-09-18
HUP0402142A2 (hu) 2005-02-28
DE10294402D2 (de) 2004-11-11
PL373494A1 (en) 2005-09-05
NO20034159D0 (no) 2003-09-18
CA2462075A1 (en) 2003-04-10
KR20040037097A (ko) 2004-05-04
CN1561217A (zh) 2005-01-05
JP2005507394A (ja) 2005-03-17
MXPA04002771A (es) 2004-06-29
EP1434586A1 (de) 2004-07-07
ZA200402458B (en) 2006-07-26
RU2004113305A (ru) 2005-07-10
WO2003028735A1 (de) 2003-04-10
US20040266745A1 (en) 2004-12-30
IL161105A0 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
ID30590A (id) Celana sekali pakai jenis-celana pendek
AR027938A1 (es) Compuestos uracilo y utilizacion de los mismos
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
EP1412378A4 (en) APTAMERS AND ANTIAPTAMERS
EP1298180A4 (en) HYDROPHOBIC AND LIPOPHOBE COMPOSITION
BRPI0407773B1 (pt) preparaÇço e uso de composiÇço catalisadora
NO20041272L (no) Tetracycline derivatives and methods of use thereof
EP1349613A4 (en) THROMBOPOIETINMIMETIKA
NO20034159L (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
ID30187A (id) Dongkrak jenis pantagraf
NO20035121D0 (no) Ny anvendelse
PT1390516E (pt) Novos vectores de expressão e uso dos mesmos
EP1351388A4 (en) PHASE SLIDER AND MULTIBIT PHASE SLIDER
NO20041968L (no) Anvendelse av cystationin
FI20010410L (fi) Mukaanottaja ja lukituslaite
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
NO20033919L (no) Ny anvendelse
DE60205008D1 (de) Kettelverfahren und -vorrichtung
ID30381A (id) Penggunaan arilalkanoilpiridazina
DK1366039T3 (da) Piperazinylcarbonylquinoliner og -isoquinoliner
DE60219418D1 (de) Silanylphenole und -naphthole
ATE354561T1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen
DE50202827D1 (de) Wand- Decken und Schallschutzelement
DE60140770D1 (de) Fixier- und zwischenübertragungsrollen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]